MGR Foamtex Ltd., world-leader in the design, development and manufacture of advanced passenger upholstery systems for premium cabin seating, has announced that its advanced antimicrobial MGRSafeWall™ product protection system has been successfully tested against SARS-CoV-2, the virus that causes COVID-19, using Addmaster Biomaster antimicrobial technology.
“The aircraft and airline industries are actively working to adapt to the new normal when flying will be frequent again. MGR Foamtex is one of several new partners supplying antimicrobial materials for aircraft seats, upholstery and interiors to make the cabin as safe as possible. This is an area where Polygiene’s and Addmaster’s antimicrobial solutions will add value and work as a second line of defence in addition to regular cleaning, and we anticipate an increased demand for this kind of functionality going forward”, says Ulrika Björk, CEO of Polygiene.
Laboratory testing to ISO 18184 protocols using MGRSafeWall and real aircraft cabin products has demonstrated efficacy of 96.8% against SARS-CoV-2. In addition to the viral testing, MGRSafeWall has also shown excellent behavior in flammability, abrasion and resistance to cleaning agent tests.
MGR Foamtex first partnered with Addmaster for the use of Biomaster antimicrobial technology in its new MGRSafeWall product range in August 2020.
Surfaces treated with Biomaster technology are proven to reduce the microbial load and the opportunities for cross contamination and provide an important second line of defense in addition to regular cleaning protocols.
The active antimicrobial agent is built into the product during the manufacturing process, so the product protection is effective for the useful lifetime of the item.